Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 2Leukemia 2Hematologic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Participation 1Myelodysplastic Syndromes 1Bronchiolitis Obliterans Syndrome 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Anemia 1

Interventions

fludarabine phosphate 5fludarabine 5Cyclophosphamide 5Whole-Body Irradiation 4Busulfan 3Antilymphocyte Serum 3Thiotepa 2Mycophenolic Acid 2Melphalan 2Alemtuzumab 2posaconazole 1eltrombopag 1Therapeutics 1Tacrolimus 1Specimen Handling 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Passive Cutaneous Anaphylaxis 1Morphine 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methadone 1Hydromorphone 1Genetic Counseling 1Erythrocyte Transfusion 1Cyclosporins 1Clofarabine 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Blood Transfusion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Marrow Failure Disorders × Blood Transfusion × Other hematologic neoplasm × Clear all
NCT03086252 2018-07-26

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Emory University

Phase NA Withdrawn
Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡